Medicare Enrolled
Dr. Darren Lackan, M.D.
Endocrinology · Ft Worth, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lackan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lackan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lackan
Dr. Darren Lackan is an endocrinology specialist in Ft Worth, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Lackan performed 3,127 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Lackan received a total of $16,681 from 68 pharmaceutical and/or device companies across 573 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lackan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 13% volume in TX
$16,681 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,127
Medicare services
Top 13% in TX for endocrinology
Not available
Unique patients (not deduplicated)
$96
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,276 | $91 | $190 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
705 | $82 | $275 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
253 | $64 | $125 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
208 | $25 | $87 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
202 | $123 | $310 |
| Ultrasound-guided fine needle aspiration biopsy, first lesion A biopsy procedure where a thin needle is used to collect tissue samples from a growth, guided by ultrasound imaging. This code applies to the first lesion or mass sampled during the session. |
188 | $103 | $385 |
| Ultrasound-guided fine needle aspiration biopsy, each additional growth This procedure involves using ultrasound guidance to perform a fine needle aspiration biopsy on an additional growth during the same session. |
132 | $46 | $185 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
55 | $11 | $60 |
| Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg vial | 30 | $1,549 | $3,480 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
28 | $133 | $280 |
| New patient office visit, complex (60-74 min) | 20 | $172 | $395 |
| Injection, cosyntropin, 0.25 mg | 18 | $20 | $300 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
12 | $38 | $275 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$16,681
Total received (2018-2024)
Avg $2,383/year across 7 years
Top 24% in TX for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
68
Companies
573
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,616
2023
$1,970
2022
$1,206
2021
$1,638
2020
$1,273
2019
$1,389
2018
$6,589
Payments by company (2024)
Abbott Laboratories
$378
Amgen Inc.
$293
Lilly USA, LLC
$274
Novo Nordisk Inc
$260
Dexcom, Inc.
$110
Alvogen Inc
$104
Nevro Corp.
$101
Corcept Therapeutics
$85
Xeris Pharmaceuticals, Inc.
$81
SANOFI-AVENTIS U.S. LLC
$76
ABBVIE INC.
$75
Tandem Diabetes Care, Inc.
$63
Boehringer Ingelheim Pharmaceuticals, Inc.
$57
Insulet Corporation
$56
Neurocrine Biosciences, Inc.
$56
CeQur Corporation
$55
PFIZER INC.
$49
Novartis Pharmaceuticals Corporation
$48
Mannkind Corporation
$43
Kyowa Kirin, Inc.
$41
Chiesi USA, Inc.
$41
Medtronic, Inc.
$38
RECORDATI_RARE_DISEASES_INC.
$36
IBSA Pharma Inc.
$34
Eisai Inc.
$34
BETA BIONICS, INC.
$30
Endo Pharmaceuticals Inc.
$21
Alexion Pharmaceuticals, Inc.
$20
Echosens North America, Inc.
$15
Antares Pharma, Inc.
$15
Regeneron Healthcare Solutions, Inc.
$14
Tolmar, Inc.
$13
Top 3 companies account for 36.1% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$6,441
Abbott Laboratories
$1,161
Novo Nordisk Inc
$994
Tandem Diabetes Care, Inc.
$913
Amgen Inc.
$531
Dexcom, Inc.
$518
Lilly USA, LLC
$508
Boehringer Ingelheim Pharmaceuticals, Inc.
$427
SANOFI-AVENTIS U.S. LLC
$405
AbbVie Inc.
$326
Amarin Pharma Inc.
$271
Mannkind Corporation
$258
Horizon Therapeutics plc
$252
Nevro Corp.
$252
CeQur Corporation
$226
ABBVIE INC.
$220
Xeris Pharmaceuticals, Inc.
$219
Alexion Pharmaceuticals, Inc.
$206
PFIZER INC.
$169
Radius Health, Inc.
$167
Medtronic, Inc.
$142
AbbVie, Inc.
$138
IBSA Pharma Inc.
$133
Corcept Therapeutics
$130
Insulet Corporation
$119
Alvogen Inc
$104
Antares Pharma, Inc.
$86
Ultragenyx Pharmaceutical Inc.
$78
Medtronic MiniMed, Inc.
$73
Ipsen Biopharmaceuticals, Inc
$72
DEXCOM, INC.
$62
RECORDATI_RARE_DISEASES_INC.
$61
Shire North American Group Inc
$60
Neurocrine Biosciences, Inc.
$56
Novartis Pharmaceuticals Corporation
$48
Strongbridge US INC.
$47
Clarus Therapeutics Inc.
$47
Merck Sharp & Dohme Corporation
$45
MannKind Corporation
$42
Kyowa Kirin, Inc.
$41
Chiesi USA, Inc.
$41
Endo Pharmaceuticals Inc.
$39
Intuity Medical Inc
$37
Amneal Pharmaceuticals LLC
$36
Blueprint Medicines Corporation
$36
Eisai Inc.
$34
Acella Pharmaceuticals, LLC
$33
Bayer Healthcare Pharmaceuticals Inc.
$32
BETA BIONICS, INC.
$30
Tolmar, Inc.
$27
VIVUS LLC
$26
EISAI INC.
$25
Supernus Pharmaceuticals, Inc.
$22
Esperion Therapeutics, Inc.
$20
Optos, Inc.
$18
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$17
Zealand Pharma US, Inc.
$17
Bayer HealthCare Pharmaceuticals Inc.
$15
Echosens North America, Inc.
$15
Regeneron Healthcare Solutions, Inc.
$14
Merck Sharp & Dohme LLC
$14
Currax Pharmaceuticals LLC
$14
VIVUS, Inc.
$13
Valeritas, Inc.
$13
Senseonics, Incorporated
$12
LifeScan, Inc.
$12
Roche Diabetes Care, Inc.
$12
Ascensia Diabetes Care US Inc.
$11
Top 3 companies account for 51.5% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AVEED · BOTOX · CONTRAVE · CYCLOSET · CeQur Simplicity · Corlanor · Crysvita · Cryvista · DC ACCU-CHEK Education Materials · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom CGM · Dexcom G6 Transmitter · EVENITY · EVKEEZA · Eversense · FARXIGA · FIASP · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FibroScan · FreeStyle Libre · GAVRETO · GVOKE HYPOPEN · GVOKE PFS · HUMALOG · HUMULIN · InPen · JANUVIA · JARDIANCE · JATENZO · KEVEYIS · Kerendia · Korlym · LEQVIO · LICART · LYUMJEV · Lenvima · MINIMED 770G · MINIMED 780G · MOUNJARO · MYCAPSSA · Minimed 670G System · Minimed 770G System · NATPARA · NEXLETOL · NOCDURNA · NP Thyroid 60 · OCT OPHTHALMOSCOPE · Omnia · Omnipod · OneTouch · Ozempic · PRALUENT · PROCLAIM · Pogo Automatic Blood Glucose Monitoring System · Prolia · QSYMIA · Qsymia · RECORLEV · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · STEGLUJAN · STRENSIQ · SYNTHROID · Saxenda · Senza · Somatuline Depot · Strensiq · Synthroid · TEPEZZA · TERIPARATIDE · TOUJEO · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · UNITHROID · V-GO · Vascepa · Wegovy · XYOSTED · ZEGALOGUE · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Endocrinologists in nearby ZIP areas
24
County median income
$81,905
Nearest hospital to ZIP centroid (approximate)
TEXAS HEALTH HARRIS METHODIST HOSPITAL SOUTHWEST F
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lackan is a clinical cardiology specialist, with above-average Medicare volume (top 13% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lackan experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Lackan performed 1,276 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Lackan receive payments from pharmaceutical companies?
Yes. Dr. Lackan received a total of $16,681 from 68 companies across 573 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lackan's costs compare to other endocrinologists in Ft Worth?
Dr. Lackan's average Medicare payment per service is $96. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lackan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Ft Worth
Browse endocrinologists in Ft Worth ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in TX
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in TX
Which TX endocrinologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology